Caina shares (301122.SZ) plans to acquire no less than 20% equity of Peptide Biotech by means of cash payment.

Zhito Finance APP News: Cainiao Co., Ltd. (301122.SZ) announced that the company is planning to acquire no less than 20% of the equity of Zhejiang Peptide Biotech Co., Ltd. ("Peptide Biotech") by way of cash payment. On September 24, 2026, the company signed a Letter of Intent for Acquisition with Xing Haiying, Shengzhou Hanyuan Investment Management Partnership (Limited Partnership), Shengzhou Fuding Biotechnology Partnership (Limited Partnership), Liu Zhiguo, Shengzhou Fuyue Investment Management Partnership (Limited Partnership), Shengzhou Xinghan Investment Management Partnership (Limited Partnership), Shengzhou Zhongxin Enterprise Management Partnership (Limited Partnership), and Peptide Biotech.